Natco Pharma Limited has announced a leadership reshuffle within its research and development arsenal, elevating two internal executives to key senior roles to strengthen its analytical and formulation disciplines. Effective 6 July 2026, Gnanadeva Chalapathy Gudipati has been designated Senior Vice President – Analytical Research & Development, while Madhava Rao Karicherla has been appointed Vice President – Formulation Research & Development, Pharma Division, Kothur Unit. The moves reflect Natco’s ongoing emphasis on strengthening core R&D capabilities to accelerate innovation and product readiness across its portfolio.